300115 | Dox-NP™ (5mL vial)
Dox-NP™ (Liposomal Encapsulated Doxorubicin)
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Dox-NP™ (5mL vial)
Dox-NP™ (Liposomal Encapsulated Doxorubicin)
Formulation: A Pegylated, long-circulating liposomal formulation with doxorubicin entrapped within an ammonium sulfate core via remote-loading. All unencapsulated was removed to yield a completely liposomal doxorubicin product. Liposomes are stored frozen for a longer shelf life.
Buffer: 10% w/v sucrose, 10 mM histidine buffer
Recommended applications: Intravenous (i.v.) injection in flank or orthotopic animal models of cancer
Storage conditions: Store frozen (-20ºC) until ready for use
Parot J, Caputo F, Mehn D, Hackley VA, Calzolai L. Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation. J Control Release. 2020 Jan 28;320:495-510. doi: 10.1016/j.jconrel.2020.01.049. Epub ahead of print. PMID: 32004590.
PubMed ID: 32004590- Certificate of Analysis (Lot No. 300115S-1EA-010 and 6565SAA010)
- Certificate of Analysis (Lot No. 300115S-1EA-011 and 6565SAA011)
- Certificate of Analysis (Lot No. 300115S-1EA-012 and 6565SAA012)